MK Proteins Intrinsic Value
MK Proteins (MKPL) median intrinsic value is ₹7.94 from 9 valuation models (range ₹1–₹10), vs current price ₹3.97 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Check MKPL company valuation to track the company's total market size over time.
MKPL Valuation Methods Summary — DCF, Graham Number & P/E
MK Proteins intrinsic value across 9 models vs current price ₹3.97 — upside/downside and value range per method. For current market price and key ratios, visit MKPL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1.20 | ₹0.96 - ₹1.44 | -69.8% | EPS: ₹0.10, Sector P/E: 12x |
| Book Value Method | asset | ₹9.93 | ₹8.94 - ₹10.92 | +150.1% | Book Value/Share: ₹20.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹7.94 | ₹7.15 - ₹8.73 | +100.0% | Revenue/Share: ₹100.79, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹7.94 | ₹7.15 - ₹8.73 | +100.0% | EBITDA: ₹9.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹9.93 | ₹7.94 - ₹11.92 | +150.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.19 | ₹1.07 - ₹1.31 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.19 | ₹1.07 - ₹1.31 | -70.0% | Revenue Growth: 5.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹7.94 | ₹7.15 - ₹8.73 | +100.0% | ROE: 6.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹6.71 | ₹6.04 - ₹7.38 | +69.0% | EPS: ₹0.10, BVPS: ₹20.00 |
MKPL Intrinsic Value vs Market Price — All Valuation Models
MK Proteins fair value range ₹1–₹10 vs current market price ₹3.97 across 9 valuation models. See MK Proteins P/B valuation to compare market price against book value per share.
MKPL Intrinsic Value Analysis — Undervalued or Overvalued?
MK Proteins median intrinsic value ₹7.94, current price ₹3.97 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of MKPL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of MK Proteins (MKPL) is ₹7.94 (median value). With the current market price of ₹3.97, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹1.19 to ₹9.93, indicating ₹1.19 - ₹9.93.
Is MKPL undervalued or overvalued?
Based on our multi-method analysis, MK Proteins (MKPL) appears to be trading below calculated value by approximately 100.0%.
MKPL Financial Health — Key Ratios vs Industry Benchmarks
MK Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 59.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 6.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.92x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MKPL Cash Flow Quality — Operating & Free Cash Flow
MK Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-16 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹32 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-10 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |